Crescent Biopharma (CBIO) Accumulated Expenses (2013 - 2026)
Crescent Biopharma (CBIO) posted Accumulated Expenses of $7.41 million for Q2 2026, down 2.6% from $7.61 million a year earlier but up 67.1% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Crescent Biopharma's Accumulated Expenses came in at $16.34 million, up 634.6% from FY2024.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- In prior years, Crescent Biopharma's Accumulated Expenses was $2.23 million in FY2024 (-57.4%), $5.23 million in FY2023 (-25.3%), $6.99 million in FY2022 (-19.8%) and $8.72 million in FY2021 (-7.7%).
- Quarterly Accumulated Expenses has run from a low of $2.23 million in Q4 2024 to a high of $16.34 million in Q4 2025 over five years.
- On a year-over-year basis, Accumulated Expenses increased in four of the last eight quarters, with growth averaging 112.0%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q4 2025, with growth of 634.6%; the weakest was Q4 2024, with a decline of 57.4%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $4.43 million (Q1 2026), $16.34 million (Q4 2025) and $8.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Crescent Biopharma | 404.96 Mn | -302.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.41 Mn |
| Mar 31, 2026 | 4.43 Mn |
| Dec 31, 2025 | 16.34 Mn |
| Sep 30, 2025 | 8.97 Mn |
| Jun 30, 2025 | 7.61 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 2.96 Mn |
| Mar 31, 2024 | 3.91 Mn |
| Dec 31, 2023 | 5.23 Mn |
| Sep 30, 2023 | 5.31 Mn |
| Jun 30, 2023 | 5.51 Mn |
| Mar 31, 2023 | 5.61 Mn |
| Dec 31, 2022 | 6.99 Mn |
| Sep 30, 2022 | 5.81 Mn |
| Jun 30, 2022 | 6.61 Mn |
| Mar 31, 2022 | 9.48 Mn |
| Dec 31, 2021 | 8.72 Mn |
| Sep 30, 2021 | 7.30 Mn |
API Access
Crescent Biopharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();